INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Ovarian Cancer|Bladder Cancer|Non Small Cell Lung Cancer|Squamous Cell Carcinoma of Head and Neck|Triple Negative Breast Cancer|Castration Resistant Prostate Cancer|Colorectal Cancer|Gastric/ Gastroesophageal Junction|Hepatocellular Carcinoma|Pancreatic Ductal Adenocarcinoma|Squamous Carcinoma of the Anal Canal
Interventions: DRUG: INCB106385|DRUG: INCMGA00012
Sponsor: Incyte Corporation